Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT05209256
Status:
UNKNOWN
Last Update Posted:
2022-01-26
First Post:
2022-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC
Sponsor:
The First Affiliated Hospital of Henan University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ALF-IN-NSCLC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None